- Ozempic, a diabetes drug now used for weight loss, is part of a massive fraud that could harm millions, especially children, by treating obesity without addressing its root causes.
- The obesity epidemic is driven in part by ultra-processed foods designed to override natural satiety mechanisms, not by a lack of weight loss drugs like Ozempic.
- The Treat and Reduce Obesity Act could mandate government coverage for obesity medications for 74% of Americans, costing over $3 trillion annually without addressing underlying health issues.
- Ozempic’s maker, Novo Nordisk, has become a top lobbying spender in the U.S., pushing for expanded drug coverage while downplaying significant side effects like muscle loss, suicidal thoughts and increased cancer risk.
- Naturally increasing GLP-1 levels through gut bacteria like Akkermansia muciniphila offers an alternative to Ozempic, promoting overall gut health without the risks associated with long-term pharmaceutical use.
The rise of Ozempic and similar drugs for weight loss involves fraud of unprecedented scale that could have devastating consequences for millions of Americans, especially children.
Ozempic, a drug initially developed for diabetes, has become a sensation for weight loss. Its popularity has skyrocketed, with everyone from celebrities to college students clamoring for prescriptions — but at what cost?
The active ingredient in Ozempic is part of a class of drugs called glucagon-like peptide-1 (GLP-1) agonists.
These drugs stimulate hormones in your digestive system that signal fullness. While this makes it easier for people to eat less and lose weight, the reality is far more complex and concerning.
Hellbound and Down 